End-of-day quote
Other stock markets
|
||
- HKD | - |
Apr. 23 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
Apr. 23 | BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise | MT |
Sales 2024 * | 3.08B 24.11B | Sales 2025 * | 3.92B 30.66B | Capitalization | 16.09B 126B |
---|---|---|---|---|---|
Net income 2024 * | -892M -6.98B | Net income 2025 * | -356M -2.78B | EV / Sales 2024 * | 4.74 x |
Net cash position 2024 * | 1.48B 11.59B | Net cash position 2025 * | 1.13B 8.84B | EV / Sales 2025 * | 3.81 x |
P/E ratio 2024 * |
-18
x | P/E ratio 2025 * |
-42.4
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.21% |
Latest transcript on Beigene Ltd
1st Jan change | Capi. | |
---|---|---|
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-9.21% | 18.14B | |
-39.98% | 17.02B | |
+4.39% | 13.83B | |
+31.35% | 11.97B | |
+327.62% | 8.78B |